Cullin 5 destabilizes cas to inhibit src-dependent cell transformation

Journal of Cell Science

Volumn 127, Issue 3, 2014, Pages 509-520

  Teckchandani, Anjali ^a   Laszlo, George S ^a   Simó, Sergi ^a   Shah, Khyati ^a,c   Pilling, Carissa ^a,b   Strait, Alexander A ^a,d   Cooper, Jonathan A ^a,b  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BioControl Systems Inc   (United States)

^d UNIVERSITY OF COLORADO   (United States)

Author keywords

Cas; Cul5; Cullin 5; Migration; Src; Transformation; Ubiquitin

Indexed keywords

CAS; CUL5; CULLIN 5; MIGRATION; SRC; TRANSFORMATION; UBIQUITIN;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CRK-ASSOCIATED SUBSTRATE PROTEIN; CULLIN PROTEINS; EPITHELIAL CELLS; GENE KNOCKDOWN TECHNIQUES; MICE; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84894096603     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.127829     Document Type: Article

References (56)

1. Bouton, A. H., Riggins, R. B. and Bruce-Staskal, P. J. (2001). Functions of the adapter protein Cas: signal convergence and the determination of cellular responses. Oncogene 20, 6448-6458.
2. Cabodi, S., Tinnirello, A., Di Stefano, P., Bisarò , B., Ambrosino, E., Castellano, I., Sapino, A., Arisio, R., Cavallo, F., Forni, G. et al. (2006). p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res. 66, 4672-4680.
3. Cheresh, D. A., Leng, J. and Klemke, R. L. (1999). Regulation of cell contraction and membrane ruffling by distinct signals in migratory cells. J. Cell Biol. 146, 1107-1116.
4. Debnath, J. and Brugge, J. S. (2005). Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675-688.
5. Debnath, J., Mills, K. R., Collins, N. L., Reginato, M. J., Muthuswamy, S. K. and Brugge, J. S. (2002). The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29-40.
6. Debnath, J., Muthuswamy, S. K. and Brugge, J. S. (2003). Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256-268.
7. Deshaies, R. J. and Joazeiro, C. A. (2009). RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399-434.
8. Dow, L. E., Kauffman, J. S., Caddy, J., Zarbalis, K., Peterson, A. S., Jane, S. M., Russell, S. M. and Humbert, P. O. (2007). The tumoursuppressor Scribble dictates cell polarity during directed epithelial migration: regulation of Rho GTPase recruitment to the leading edge. Oncogene 26, 2272-2282.
9. Elliott, J., Hookham, M. B. and Johnston, J. A. (2008). The suppressors of cytokine signalling E3 ligases behave as tumour suppressors. Biochem. Soc. Trans. 36, 464-468.
10. Farabegoli, F., Ceccarelli, C., Santini, D. and Taffurelli, M. (2005). Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma. J. Clin. Pathol. 58, 1046-1050.
11. Fay, M. J., Longo, K. A., Karathanasis, G. A., Shope, D. M., Mandernach, C. J., Leong, J. R., Hicks, A., Pherson, K. and Husain, A. (2003). Analysis of CUL-5 expression in breast epithelial cells, breast cancer cell lines, normal tissues and tumor tissues. Mol. Cancer 2, 40.
12. Hakak, Y. and Martin, G. S. (1999). Ubiquitin-dependent degradation of active Src. Curr. Biol. 9, 1039.
13. Hampton, G. M., Mannermaa, A., Winqvist, R., Alavaikko, M., Blanco, G., Taskinen, P. J., Kiviniemi, H., Newsham, I., Cavenee, W. K. and Evans, G. A. (1994). Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res. 54, 4586-4589.
14. Harris, K. F., Shoji, I., Cooper, E. M., Kumar, S., Oda, H. and Howley, P. M. (1999). Ubiquitin-mediated degradation of active Src tyrosine kinase. Proc. Natl. Acad. Sci. USA 96, 13738-13743.
15. Herranz, H., Hong, X., Hung, N. T., Voorhoeve, P. M. and Cohen, S. M. (2012). Oncogenic cooperation between SOCS family proteins and EGFR identified using a Drosophila epithelial transformation model. Genes Dev. 26, 1602-1611.
16. Howell, B. W. and Cooper, J. A. (1994). Csk suppression of Src involves movement of Csk to sites of Src activity. Mol. Cell. Biol. 14, 5402-5411.
17. Huang, D. T., Ayrault, O., Hunt, H. W., Taherbhoy, A. M., Duda, D. M., Scott, D. C., Borg, L. A., Neale, G., Murray, P. J., Roussel, M. F. et al. (2009).E2-RING expansion of the NEDD8 cascade confers specificity to cullin modification. Mol. Cell 33, 483-495.
18. Hunter, T. (2009). Tyrosine phosphorylation: thirty years and counting. Curr. Opin. Cell Biol. 21, 140-146.
19. Imamoto, A. and Soriano, P. (1993). Disruption of the csk gene, encoding a negative regulator of Src family tyrosine kinases, leads to neural tube defects and embryonic lethality in mice. Cell 73, 1117-1124.
20. Ishizawar, R. and Parsons, S. J. (2004). c-Src and cooperating partners in human cancer. Cancer Cell 6, 209-214.
21. Johnson, A. E., Le, I. P., Buchwalter, A. and Burnatowska-Hledin, M. A. (2007). Estrogen-dependent growth and estrogen receptor (ER)-alpha concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene. Mol. Cell. Biochem. 301, 13-20.
22. Kamura, T., Maenaka, K., Kotoshiba, S., Matsumoto, M., Kohda, D., Conaway, R. C., Conaway, J. W. and Nakayama, K. I. (2004). VHL-box and SOCS-box domains determine binding specificity for Cul2-Rbx1 and Cul5-Rbx2 modules of ubiquitin ligases. Genes Dev. 18, 3055-3065.
23. Kile, B. T., Schulman, B. A., Alexander, W. S., Nicola, N. A., Martin, H. M. and Hilton, D. J. (2002). The SOCS box: a tale of destruction and degradation. Trends Biochem. Sci. 27, 235-241.
24. King, N., Westbrook, M. J., Young, S. L., Kuo, A., Abedin, M., Chapman, J., Fairclough, S., Hellsten, U., Isogai, Y., Letunic, I. et al. (2008). The genome of the choanoflagellate Monosiga brevicollis and the origin of metazoans. Nature 451, 783-788.
25. Klemke, R. L., Leng, J., Molander, R., Brooks, P. C., Vuori, K. and Cheresh, D. A. (1998). CAS/Crk coupling serves as a "molecular switch' for induction of cell migration. J. Cell Biol. 140, 961-972.
26. Kline, C. L., Jackson, R., Engelman, R., Pledger, W. J., Yeatman, T. J. and Irby, R. B. (2008). Src kinase induces tumor formation in the c-SRC C57BL/6 mouse. Int. J. Cancer 122, 2665-2673.
27. Krishnan, H., Miller, W. T. and Goldberg, G. S. (2012). SRC points the way to biomarkers and chemotherapeutic targets. Genes Cancer 3, 426-435.
28. Lai, R. H., Hsiao, Y. W., Wang, M. J., Lin, H. Y., Wu, C. W., Chi, C. W., Li, A. F., Jou, Y. S. and Chen, J. Y. (2010). SOCS6, down-regulated in gastric cancer, inhibits cell proliferation and colony formation. Cancer Lett. 288, 75-85.
29. Laszlo, G. S. and Cooper, J. A. (2009). Restriction of Src activity by Cullin-5. Curr. Biol. 19, 157-162.
30. Lee, J. and Zhou, P. (2010). Cullins and cancer. Genes Cancer 1, 690-699.
31. Lin, G., Aranda, V., Muthuswamy, S. K. and Tonks, N. K. (2011). Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'. Genes Dev. 25, 1412-1425.
32. Liongue, C., O'Sullivan, L. A., Trengove, M. C. and Ward, A. C. (2012). Evolution of JAK-STAT pathway components: mechanisms and role in immune system development. PLoS ONE 7, e32777.
33. Matsui, H., Harada, I. and Sawada, Y. (2012). Src, p130Cas, and Mechanotransduction in Cancer Cells. Genes Cancer 3, 394-401.
34. Miller, A. D. and Rosman, G. J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-982, 984-986, 989-990.
35. Muthuswamy, S. K., Li, D., Lelievre, S., Bissell, M. J. and Brugge, J. S. (2001). ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3, 785-792.
36. Nada, S., Yagi, T., Takeda, H., Tokunaga, T., Nakagawa, H., Ikawa, Y., Okada, M. and Aizawa, S. (1993). Constitutive activation of Src family kinases in mouse embryos that lack Csk. Cell 73, 1125-1135.
37. Okumura, F., Matsuzaki, M., Nakatsukasa, K. and Kamura, T. (2012). The Role of Elongin BC-Containing Ubiquitin Ligases. Front Oncol. 2, 10.
38. Pan, Q., Qiao, F., Gao, C., Norman, B., Optican, L. and Zelenka, P. S. (2011). Cdk5 targets active Src for ubiquitin-dependent degradation by phosphorylating Src(S75). Cell. Mol. Life Sci. 68, 3425-3436.
39. Pawson, T., Gish, G. D. and Nash, P. (2001). SH2 domains, interaction modules and cellular wiring. Trends Cell Biol. 11, 504-511.
40. Petroski, M. D. and Deshaies, R. J. (2005). Function and regulation of cullin-RING ubiquitin ligases. Nat. Rev. Mol. Cell Biol. 6, 9-20.
41. Reginato, M. J., Mills, K. R., Becker, E. B., Lynch, D. K., Bonni, A., Muthuswamy, S. K. and Brugge, J. S. (2005). Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol. Cell. Biol. 25, 4591-4601.
42. Sasi, W., Jiang, W. G., Sharma, A. and Mokbel, K. (2010). Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer. BMC Cancer 10, 178.
43. Sawada, Y., Tamada, M., Dubin-Thaler, B. J., Cherniavskaya, O., Sakai, R., Tanaka, S. and Sheetz, M. P. (2006). Force sensing by mechanical extension of the Src family kinase substrate p130Cas. Cell 127, 1015-1026.
44. Schrecengost, R. S., Riggins, R. B., Thomas, K. S., Guerrero, M. S. and Bouton, A. H. (2007). Breast cancer antiestrogen resistance-3 expression regulates breast cancer cell migration through promotion of p130Cas membrane localization and membrane ruffling. Cancer Res. 67, 6174-6182.
45. Sharma, A. and Mayer, B. J. (2008). Phosphorylation of p130Cas initiates Rac activation and membrane ruffling. BMC Cell Biol. 9, 50.
46. Shin, N. Y., Dise, R. S., Schneider-Mergener, J., Ritchie, M. D., Kilkenny, D. M. and Hanks, S. K. (2004). Subsets of the major tyrosine phosphorylation sites in Crk-associated substrate (CAS) are sufficient to promote cell migration. J. Biol. Chem. 279, 38331-38337.
47. Sriram, K. B., Larsen, J. E., Savarimuthu Francis, S. M., Wright, C. M., Clarke, B. E., Duhig, E. E., Brown, K. M., Hayward, N. K., Yang, I. A., Bowman, R. V. et al. (2012). Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma. PLoS ONE 7, e30398.
48. Stupack, D. G., Cho, S. Y. and Klemke, R. L. (2000). Molecular signaling mechanisms of cell migration and invasion. Immunol. Res. 21, 83-88.
49. Summy, J. M. and Gallick, G. E. (2003). Src family kinases in tumor progression and metastasis. Cancer Metastasis Rev. 22, 337-358.
50. Sutherland, K. D., Lindeman, G. J., Choong, D. Y., Wittlin, S., Brentzell, L., Phillips, W., Campbell, I. G. and Visvader, J. E. (2004). Differential hypermethylation of SOCS genes in ovarian and breast carcinomas. Oncogene 23, 7726-7733.
51. Tornillo, G., Bisaro, B., Camacho-Leal, M. P., Galiè , M., Provero, P., Di Stefano, P., Turco, E., Defilippi, P. and Cabodi, S. (2011). p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. Eur. J. Cell Biol. 90, 237-248.
52. van der Flier, S., Brinkman, A., Look, M. P., Kok, E. M., Meijer-van Gelder, M. E., Klijn, J. G., Dorssers, L. C. and Foekens, J. A. (2000). Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment. J. Natl. Cancer Inst. 92, 120-127.
53. Wang, Q., Diskin, S., Rappaport, E., Attiyeh, E., Mosse, Y., Shue, D., Seiser, E., Jagannathan, J., Shusterman, S., Bansal, M. et al. (2006). Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number. Cancer Res. 66, 6050-6062.
54. Wrobel, C. N., Debnath, J., Lin, E., Beausoleil, S., Roussel, M. F. and Brugge, J. S. (2004). Autocrine CSF-1R activation promotes Src-dependent disruption of mammary epithelial architecture. J. Cell Biol. 165, 263-273.
55. Yi, E. C., Lee, H., Aebersold, R. and Goodlett, D. R. (2003). A microcapillary trap cartridge-microcapillary high-performance liquid chromatography electrospray ionization emitter device capable of peptide tandem mass spectrometry at the attomole level on an ion trap mass spectrometer with automated routine operation. Rapid Commun. Mass Spectrom. 17, 2093-2098.
56. Zhang, Y., Wolf-Yadlin, A., Ross, P. L., Pappin, D. J., Rush, J., Lauffenburger, D. A. and White, F. M. (2005). Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 4, 1240-1250.